2026 Douglas T. Fearon: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	107	540	500	325	295	313	56296
Medicine	108	5906	5549	3166	2937	317	57265

Research.com Recognitions

2001 - Member of the National Academy of Sciences
1999 - Fellow of the Royal Society, United Kingdom
1999 - Fellow of the American Academy of Arts and Sciences
1990 - Fellow of the American Association for the Advancement of Science (AAAS)
Fellow of The Academy of Medical Sciences, United Kingdom
Member of the Association of American Physicians
Member of the European Molecular Biology Organization (EMBO)
Fellow of The Academy of Medical Sciences, United Kingdom
Member of the Association of American Physicians
Member of the European Molecular Biology Organization (EMBO)
Fellow of The Academy of Medical Sciences, United Kingdom
Member of the Association of American Physicians
Member of the European Molecular Biology Organization (EMBO)
Fellow of The Academy of Medical Sciences, United Kingdom
Member of the Association of American Physicians
Member of the European Molecular Biology Organization (EMBO)

Overview

Douglas T. Fearon is affiliated with Cold Spring Harbor Laboratory in the United States. Their research focuses on multiple areas within medicine, immunology and microbiology, and biochemistry, genetics and molecular biology, with particular emphasis on immunology, oncology, molecular biology, cell biology, and epidemiology.

The scientist's work covers several major topics including immunotherapy and immune responses, CAR-T cell therapy research, immune cell function and interaction, cancer immunotherapy and biomarkers, single-cell and spatial transcriptomics, T-cell and B-cell immunology, and pancreatic and hepatic oncology research.

Douglas T. Fearon has published extensively in a range of venues. Frequent publication venues include bioRxiv (Cold Spring Harbor Laboratory), Proceedings of the National Academy of Sciences, Nature, The Journal of Immunology, and Nature Reviews Cancer.

bioRxiv (Cold Spring Harbor Laboratory)
Proceedings of the National Academy of Sciences
Nature
The Journal of Immunology
Nature reviews. Cancer

Notable recent publications include:

A framework for advancing our understanding of cancer-associated fibroblasts, 2020, Nature Reviews Cancer
Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I, 2020, Nature
CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response, 2020, Proceedings of the National Academy of Sciences
Carcinomas assemble a filamentous CXCL12-keratin-19 coating that suppresses T cell-mediated immune attack, 2022, Apollo (University of Cambridge)
Cancer cell CCR2 orchestrates suppression of the adaptive immune response, 2020, The Journal of Experimental Medicine

They collaborate frequently with several coauthors, including Philip Moresco (9 publications), Tobias Janowitz (6 publications), Zhikai Wang (6 publications), David A. Tuveson (5 publications), and Ran Yan (5 publications).

Douglas T. Fearon has received multiple recognitions, including:

Member of the National Academy of Sciences, 2001
Fellow of the Royal Society, United Kingdom, 1999
Fellow of the American Academy of Arts and Sciences, 1999
Fellow of the American Association for the Advancement of Science (AAAS), 1990
Member of the Association of American Physicians
Member of the European Molecular Biology Organization (EMBO)
Fellow of The Academy of Medical Sciences, United Kingdom

Best Publications

A framework for advancing our understanding of cancer-associated fibroblasts

Erik Sahai;Igor Astsaturov;Edna Cukierman;David G. DeNardo

3566
Citations
The instructive role of innate immunity in the acquired immune response.

Douglas T. Fearon;Richard M. Locksley

2488
Citations
T cell exclusion, immune privilege, and the tumor microenvironment

Johanna A. Joyce;Douglas T. Fearon;Douglas T. Fearon

2450
Citations
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer

Daniel Öhlund;Daniel Öhlund;Daniel Öhlund;Abram Handly-Santana;Abram Handly-Santana;Giulia Biffi;Giulia Biffi;Ela Elyada;Ela Elyada

2424
Citations
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer.

Christine Feig;James O. Jones;Matthew Kraman;Richard J. B. Wells

2055
Citations
C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired Immunity

Paul W. Dempsey;Michael E. D. Allison;Srinivas Akkaraju;Christopher C. Goodnow

1545
Citations
Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice.

Jean Albrengues;Mario Anthonio Shields;David Ng;Chun Gwon Park

1380
Citations
Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.

J D Fingeroth;J J Weis;T F Tedder;J L Strominger

1272
Citations
Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α

Matthew Kraman;Paul J. Bambrough;James N. Arnold;Edward W. Roberts

1254
Citations
Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis

Harlan F. Weisman;Thomas Bartow;Michelle K. Leppo;Henry C. Marsh

1230
Citations
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.

Vinod P. Balachandran;Marta Łuksza;Julia N. Zhao;Vladimir Makarov

1213
Citations
Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I

Keisuke Yamamoto;Anthony Venida;Julian Yano;Douglas E. Biancur

1141
Citations
Distinct fibroblast subsets drive inflammation and damage in arthritis.

Adam P. Croft;Joana Campos;Kathrin Jansen;Jason D. Turner

878
Citations
Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.

DT Fearon

869
Citations
CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes

Robert H. Carter;Douglas T. Fearon

844
Citations
Control of the amplification convertase of complement by the plasma protein beta1H.

J M Weiler;M R Daha;K F Austen;D T Fearon

739
Citations
Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.

A Nicholson-Weller;J Burge;D T Fearon;P F Weller

705
Citations
Epstein-Barr Virus gp350/220 Binding to the B Lymphocyte C3d Receptor Mediates Adsorption, Capping, and Endocytosis

Jerome Tanner;Janis Weis;Janis Weis;Douglas Fearon;Douglas Fearon;Young Whang

640
Citations
A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP

G. M. Doody;L. B. Justement;C. C. Delibrias;R. J. Matthews

640
Citations
Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex.

Douglas T. Fearon;Michael C. Carroll

621
Citations
Structure and Function of the Complement Receptors, CR1 (CD35) and CR2 (CD21)

Joseph M. Ahearn;Douglas T. Fearon

615
Citations

Frequent Co-Authors

K. Frank Austen Brigham and Women's Hospital

David A. Tuveson Cold Spring Harbor Laboratory

Janis J. Weis University of Utah

Christopher D. Buckley University of Oxford

Andrew Filer University of Birmingham

Thomas F. Tedder Duke University

Mohamed R. Daha Leiden University

John A. Smith University of Alabama at Birmingham

Mikala Egeblad Cold Spring Harbor Laboratory

Francis D. Moore Brigham and Women's Hospital

External Links

Wikipedia of Douglas T. Fearon Personal website of Douglas T. Fearon

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open up diverse career pathways in healthcare and research. Many professionals in this field often pursue advanced nursing roles, such as Psychiatric-Mental Health Nurse Practitioners, where understanding immune responses is crucial. If cost is a concern, the cheapest pmhnp certificate programs offer affordable options to advance specialized expertise.

Many Immunology graduates transition into Nurse Practitioner roles, often looking to enhance their skills through bridge programs. For instance, those moving from Family Nurse Practitioner roles can benefit from an fnp to acute care np bridge program to gain critical care experience, which complements immunological knowledge in acute patient settings.

Salary potential is an important factor when selecting a career path. According to data on the highest paid dnp specialties, specialties closely aligned with Immunology-related fields often see competitive compensation, reflecting the demand for expert care and research capabilities.

For accelerated advancement, considering one of the accelerated nurse practitioner programs can fast-track your education and career. These programs are designed for motivated students and professionals seeking to enter or advance quickly within healthcare roles linked to Immunology.